Ovid Therapeutics Inc. Quarterly Current Ratio in % from Q3 2017 to Q3 2024

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Ovid Therapeutics Inc. quarterly Current Ratio history and growth rate from Q3 2017 to Q3 2024.
  • Ovid Therapeutics Inc. Current Ratio for the quarter ending September 30, 2024 was 758 %, a 44.6% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 758 -610 -44.6% Sep 30, 2024
Q2 2024 870 Jun 30, 2024
Q1 2024 1.01K Mar 31, 2024
Q4 2023 1.14K Dec 31, 2023
Q3 2023 1.37K Sep 30, 2023
Q4 2021 1.62K +1.2K +286% Dec 31, 2021
Q3 2021 1.23K +707 +137% Sep 30, 2021
Q2 2021 913 +421 +85.5% Jun 30, 2021
Q1 2021 629 +46.3 +7.95% Mar 31, 2021
Q4 2020 418 -199 -32.3% Dec 31, 2020
Q3 2020 518 -29.9 -5.46% Sep 30, 2020
Q2 2020 492 -99.1 -16.8% Jun 30, 2020
Q1 2020 582 -70.9 -10.9% Mar 31, 2020
Q4 2019 617 -104 -14.4% Dec 31, 2019
Q3 2019 548 -385 -41.2% Sep 30, 2019
Q2 2019 591 -730 -55.2% Jun 30, 2019
Q1 2019 653 -865 -57% Mar 31, 2019
Q4 2018 721 -783 -52.1% Dec 31, 2018
Q3 2018 933 -562 -37.6% Sep 30, 2018
Q2 2018 1.32K Jun 30, 2018
Q1 2018 1.52K Mar 31, 2018
Q4 2017 1.5K Dec 31, 2017
Q3 2017 1.5K Sep 30, 2017
* An asterisk sign (*) next to the value indicates that the value is likely invalid.